Report Highlights
Chronic Obstructive Pulmonary Disease MarketSize And Forecast
According to Verified Market Research, the Chronic Obstructive Pulmonary Disease Market was valued at USD 10.17 Billion in 2018 and is projected to reach USD 13.9 Billion by 2026, growing at a CAGR of 4.03% from 2019 to 2026.
Global Chronic Obstructive Pulmonary Disease Market Outlook
The high prevalence of chronic respiratory diseases, new product launches and technological advancements, and rising demand for home care therapeutics devices are some factors that are expected to boom the growth of global chronic obstructive pulmonary disease market. The increasing number of product approvals from FDA has also helped in market growth. For instance, in April 2019, Circassia Pharmaceuticals plc, announced that they have received FDA approval for Duaklir, that is specially designed for the treatment of COPD. However, the high cost of COPD treatment, increasing problem associated with patent expiry, and the dearth of awareness and knowledge among population about COPD symptoms and indications are some factors that might restrict the market growth.
Global Chronic Obstructive Pulmonary Disease Market Competitive Landscape
The Global Chronic Obstructive Pulmonary Disease Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as AstraZeneca, Astellas Pharma Inc., Abbott Laboratories, GlaxoSmithKline plc., Novartis AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Circassia Pharmaceuticals, Pfizer, Inc., and Almirall.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More